International Journal of Infectious Diseases
Volume 14, Issue 7 , Pages e596-e601 , July 2010

Evaluation of susceptibility testing methods for polymyxin

  • Bijayini Behera

      Affiliations

    • Department of Laboratory Medicine, Jai Prakash Narain Apex (JPNA) Trauma Centre, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India
    • ,
  • Purva Mathur

      Affiliations

    • Department of Laboratory Medicine, Jai Prakash Narain Apex (JPNA) Trauma Centre, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India
    • Corresponding Author InformationCorresponding author. Tel.: +91 11 26189000ext. 1169; fax: +91 11 26106826.
    • ,
  • Anupam Das

      Affiliations

    • Department of Laboratory Medicine, Jai Prakash Narain Apex (JPNA) Trauma Centre, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India
    • ,
  • Arti Kapil

      Affiliations

    • Department of Laboratory Medicine, Jai Prakash Narain Apex (JPNA) Trauma Centre, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India
    • ,
  • Babita Gupta

      Affiliations

    • Department of Anesthesiology and Critical Care, JPNA Trauma Centre, AIIMS, New Delhi, India
    • ,
  • Sanjeev Bhoi

      Affiliations

    • Department of Internal Medicine, JPNA Trauma Centre, AIIMS, New Delhi, India
    • ,
  • Kamran Farooque

      Affiliations

    • Departments of Orthopedics, JPNA Trauma Centre, AIIMS, New Delhi, India
    • ,
  • Vijay Sharma

      Affiliations

    • Departments of Orthopedics, JPNA Trauma Centre, AIIMS, New Delhi, India
    • ,
  • M.C. Misra

      Affiliations

    • Department of Surgical Disciplines, Chief JPNA Trauma Centre, AIIMS, New Delhi, India

Received 15 April 2009 ,Revised 1 September 2009 ,Accepted 2 September 2009.

References 

  1. Falagas ME, Kasiakou SK, Tsiodras S, Michalopoulos A. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin Med Res. 2006;4:138–146
  2. Arnold TM, Forrest GN, Messmer KJ. Polymyxin antibiotics for Gram-negative infections. Am J Health Syst Pharm. 2007;64:819–826
  3. Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, Athanassoupoulou P, Michalopoulos A. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis. 2005;5:24
  4. Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multi-resistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect. 2005;11:115–121
  5. Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: old antibiotics for emerging multi-resistant Gram-negative bacteria. Ann Pharmacother. 1999;33:960–967
  6. Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Manrique EI, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis. 1999;28:1008–1011
  7. Littlewood JM, Koch C, Lambert PA, Hoiby N, Elborn JS, Conway SP, et al. A ten year review of colomycin. Respir Med. 2000;94:63–71
  8. Hogardt M, Schmoldt S, Gotzfried M, Adler K, Hessemann J. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother. 2004;54:1057–1061
  9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventh informational supplement M100-S15. Wayne, PA: CLSI; 2005.
  10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventh informational supplement M100-S17. Wayne, PA: CLSI; 2007.
  11. Collee JG, Diguid JP, Fraser AG. Mackie and McCartney practical medical microbiology. 14th ed.. Edinburgh: Churchill Livingstone; 1996;
  12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 16th informational supplement M100-S16. Wayne, PA: CLSI; 2006.
  13. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 15th informational supplement, 6th ed., M7-A6. Wayne, PA: CLSI; 2003.
  14. Gales AC, Jones RN, Sader HS. Global assessment of the antimicrobial activity of polymyxin B against 54731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004). Clin Microbiol Infect. 2006;12:315–321
  15. Tan TY, Ng SY. Comparison of E-test, Vitek and agar dilution for susceptibility testing of colistin. Clin Microbiol Infect. 2007;13:541–544
  16. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 19th informational supplement. Vol. 29 (3). Wayne, PA: CLSI; 2009.
  17. van der Heijden IM, Levin AS, De Pedri EH, Fung L, Rossi F, Duboc G, et al. Comparison of disc diffusion, E-test and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins. Ann Clin Microbiol Antimicrob. 2007;6:8
  18. National Committee for Clinical and Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5, 5th ed. Wayne, PA: NCCLS; 2002.
  19. National Committee for Clinical and Laboratory Standards. Development of in vitro susceptibility testing criteria and quality control parameters. Approved standard M23-A2. Wayne, PA: NCCLS; 1981.
  20. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta lactamase producing Gram-negative bacteria in a tertiary care hospital. Indian J Med Res. 2002;115:153–157
  21. Behera B, Das A, Mathur P, Kapil A. High prevalence of carbapenem resistant Pseudomonas aeruginosa at a tertiary care centre of India. Are we under reporting?. Ind J Med Res. 2008;128:324–325
  22. Arroyo LA, Garcia-Curiel A, Pachon-lbanez ME, Llnoas AC, Ruiz M, Pachon J, et al. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005;43:903–905

PII: S1201-9712(09)00358-0

doi: 10.1016/j.ijid.2009.09.001

International Journal of Infectious Diseases
Volume 14, Issue 7 , Pages e596-e601 , July 2010

Article Tools